The AGA Journals Blog highlights the latest discoveries in gastroenterology and hepatology research.

The Fall 2021 edition of the AGA Clinician’s Companion—the go-to resource for busy clinicians who can’t afford to spend hours sifting through research to find clinical value—is available!

The AGA Clinician’s Companion summarizes high-impact findings recently published in the AGA journals Gastroenterology and Clinical Gastroenterology and Hepatology (CGH). An annual subscription provides access to the current edition as well as past issues.

Articles in the Fall 2021 edition summarize the latest research on colorectal cancer screening (feasibility of a comprehensive, automated colonoscopy audit, based on standardized documentation of colonoscopy reports and polyp pathology results) and Barrett’s esophagus surveillance (a cost-effectiveness analysis, using comparative modeling to determine the optimal age for last surveillance, based on sex comorbidities).

Other summaries cover the efficacy of COVID-19 vaccines in patients with inflammatory bowel diseases (IBD; the effectiveness of the full vaccine was 80.4% from 7 days after the 2nd dose, with no significant effects of use of immunosuppressive medications) and the ability of bariatric surgery to reduce risks of cancers in patients with severe obesity and nonalcoholic fatty liver disease (NAFLD, NASH).

The Fall 2021 Clinicians Companion discusses the finding that, in patients with chronic pancreatitis-associated benign biliary strictures, multiple plastic stents had similar efficacy and safety vs a single fully covered self-expanding metal stent (FCSEMS) during a12-month, period, with FCSEMS requiring fewer endoscopic retrograde cholangiopancreatography procedures over 2 years.

The final summary in the Fall 2021 Clinician’s Companion covers a network meta-analysis to assess and rank the comparative effectiveness of first-line dual, triple, and quadruple therapies for H pylori infection. The analysis found vonoprazan triple therapy and reverse hybrid therapy to eradicate infections in more than 90% of patients, levofloxacin triple therapy to achieve the highest eradication rates in Western countries, and standard triple therapy to be the least efficacious regimen.

Features of the AGA Clinician’s Companion include:

  • Curated articles from Gastroenterology and CGH
  • Clinical practice take-home points define the clinical utility of cutting-edge research
  • Easily accessible whether you’re in the clinic, at home or on the go
  • Articles organized by topic
  • PDF format requires no internet connection

Subscribe today!

Related Posts Plugin for WordPress, Blogger...
Kristine Novak

Kristine Novak

Leave a Replay

About The Author:

Dr. Kristine Novak

Dr. Kristine Novak

Dr. Kristine Novak is a science writer and editor based in San Francisco. She has extensive experience covering gastroenterology, hepatology, immunology, oncology, clinical, and biotechnology research discoveries.

Top Posts:


We never use your email for anything other than The AGA Journals Blog.